Corbus Pharmaceuticals Holdings (CRBP) Cash from Investing Activities (2014 - 2025)

Corbus Pharmaceuticals Holdings' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at $19.6 million for Q3 2025.

• In Q3 2025, Cash from Investing Activities rose 227.81% year-over-year to $19.6 million; the TTM figure through Sep 2025 stood at $64.2 million (up 153.68% YoY), while the FY2024 annual figure was -$121.3 million, down 440.36% from the prior year.
• Cash from Investing Activities was $19.6 million for Q3 2025 at Corbus Pharmaceuticals Holdings, up from $17.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $43.0 million in Q1 2022 to a low of -$98.2 million in Q1 2024.
• Historically, Cash from Investing Activities has averaged -$3.9 million across 5 years, with a median of $5.5 million in 2023.
• Biggest YoY gain for Cash from Investing Activities was 600.2% in 2021; the steepest drop was 80886.76% in 2021.
• A 5-year view of Cash from Investing Activities shows it stood at -$3.2 million in 2021, then soared by 470.74% to $11.8 million in 2022, then declined by 11.81% to $10.4 million in 2023, then declined by 15.96% to $8.7 million in 2024, then surged by 124.95% to $19.6 million in 2025.
• The last three Cash from Investing Activities figures came in at $19.6 million (Q3 2025), $17.7 million (Q2 2025), and $18.1 million (Q1 2025), per Business Quant data.